What is the Consensus Value of Patients’ Treatment-Risk Tolerance? Assessing a Stated-Preference Evidence Base for Inflammatory Bowel Disease

Key Points

• Patients express varying levels of treatment-risk tolerance for inflammatory bowel disease, emphasizing distinct preferences.
• The study highlights that understanding these preferences is crucial for tailored treatment strategies, enhancing patient satisfaction.
• Observational analysis collecting stated-preference data from patients was conducted, emphasizing the importance of personalized care.
• Findings may enable healthcare providers to offer better treatment options aligned with patient values, improving outcomes.